Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated
ICD-10 F13.930 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated.
F13.930 refers to a condition characterized by the use of sedative, hypnotic, or anxiolytic substances, leading to withdrawal symptoms that are uncomplicated. This diagnosis is often seen in individuals who have developed a dependence on these substances, which are commonly prescribed for anxiety, insomnia, or other related disorders. Withdrawal symptoms may include anxiety, agitation, tremors, and insomnia, but do not escalate to severe complications such as seizures or delirium. The diagnosis is classified as 'unspecified' when the specific substance is not identified, which can occur in cases where the patient is unable to recall the exact substance used or when multiple substances are involved. Treatment typically involves supportive care, monitoring of withdrawal symptoms, and may include the gradual tapering of the substance under medical supervision. Understanding the nuances of this diagnosis is crucial for effective treatment planning and accurate coding.
Detailed history of substance use, withdrawal symptoms, and treatment plan.
Patients presenting with anxiety or insomnia who have a history of sedative use.
Consideration of co-occurring mental health disorders and the need for a comprehensive treatment approach.
Thorough psychiatric evaluation, including mental status examination and substance use history.
Patients experiencing anxiety or mood disorders with a background of sedative use.
Monitoring for potential complications and the need for psychiatric intervention.
Used for follow-up visits for patients undergoing treatment for withdrawal.
Document the patient's history, symptoms, and treatment response.
Ensure that the visit is linked to the diagnosis of withdrawal.
F13.930 is used for uncomplicated withdrawal symptoms, while F13.931 is for complicated withdrawal, which may include severe symptoms such as seizures or delirium.
